2019
Chapter 49 Neonatal and Pediatric Transfusion Medicine
Zerra P, Hendrickson J, Josephson C. Chapter 49 Neonatal and Pediatric Transfusion Medicine. 2019, 295-299. DOI: 10.1016/b978-0-12-813726-0.00049-0.Peer-Reviewed Original Research
2013
Chapter 47 Neonatal and Pediatric Transfusion Medicine
Hendrickson J, Josephson C. Chapter 47 Neonatal and Pediatric Transfusion Medicine. 2013, 301-305. DOI: 10.1016/b978-0-12-397164-7.00047-1.Peer-Reviewed Original Research
2010
Use of mouse models to study the mechanisms and consequences of RBC clearance
Hod E, Arinsburg S, Francis R, Hendrickson J, Zimring J, Spitalnik S. Use of mouse models to study the mechanisms and consequences of RBC clearance. Vox Sanguinis 2010, 99: 99-111. PMID: 20345515, PMCID: PMC3580149, DOI: 10.1111/j.1423-0410.2010.01327.x.Peer-Reviewed Original ResearchConceptsMouse modelRBC clearanceImmune globulin therapyAutoimmune haemolytic anaemiaHaemolytic transfusion reactionsGlobulin therapyRBC transfusionTransfusion reactionsHaemolytic anaemiaAnimal modelsTractable animal modelTransfusion medicineCell clearanceClearancePathophysiologyHuman disordersUnanswered questionsTransfusionComplicationsAnemiaImmunomodulationTherapyMiceAntibodies
2009
Chapter 42 Neonatal and Pediatric Transfusion Medicine
Hendrickson J, Josephson C. Chapter 42 Neonatal and Pediatric Transfusion Medicine. 2009, 235-239. DOI: 10.1016/b978-0-12-374432-6.00042-7.Peer-Reviewed Original ResearchCardiopulmonary diseaseSevere cardiopulmonary diseaseSmall-volume transfusionsFebrile transfusion reactionsPediatric transfusion medicineHLA alloimmunizationSymptomatic anemiaMajor surgeryPediatric patientsPremature infantsCMV transmissionTransfusion therapyNeonatal patientsPhysiologic changesTransfusion reactionsImmune systemNeonatesFetal periodAnticoagulant-preservative solutionInfantsTransfusionRBC productsTransfusion medicineDlPatients